> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Extended on Hepatitis C Drugs Guidance
- URL: https://www.fdaweb.com/comments-extended-on-hepatitis-c-drugs-guidance/
- Published: 2016-06-27T12:00:00.000Z
- Updated: 2026-09-14T21:11:55.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136055

*Federal Register* Notice: FDA is extending the comment period for a 5/4 notice of availability of the draft guidance for industry entitled Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment. FDA is taking this action due to maintenance on the Federal eRulemaking portal from 7/1-7/5\. Comments should be submitted by 7/19\. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-06-27/pdf/2016-15098.pdf?ref=fdaweb.com)